By Alan Kotok:St. Jude Medical (STJ), a health care technology company in St. Paul, Minnesota, added this week another device to its portfolio to battle chronic pain, with a $40 million investment in the privately-owned Spinal Modulation in Menlo Park, California. The deal, announced on 7 June, gives St.
St. Jude Medical Inc. (STJ) recently received the CE Mark approval to market its Trifecta valve in Europe. The Trifecta valve is a pericardial aortic stented tissue valve used to repair a patient’s diseased, damaged or malfunctioned aortic heart valve.
By Bret Jensen:St. Jude Medical (STJ) reported lower quarterly earnings this morning, but the stock was up around 2% by today's close. Despite the drop in earnings, there are numerous reasons to be excited about this stock. First, the basics: St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide.
Boston Scientific's (BSX) stock has zoomed 10% higher this week in part due to the news that the FDA has raised fresh concerns about the defibrillator leads -- leads connect an implantable heart defibrillator device to the heart -- from St. Jude Medical (
By David Klein: St. Jude Medical (STJ) was founded in 1976 and is headquartered in St. Paul, Minnesota. Trailing twelve month 2010 net sales is 5.56 billion with 16,000 employees and a geographical scope extending to more than 100 countries.
By Canadian Dividend Growth Investor:It's great to find smaller companies which are undervalued and have growth potential. But there should be another catalyst for buying such companies. On the dip. And a big one at that.
About St. Jude Medical
Medical devices giant St. Jude Medical (STJ) is slated to report its fourth quarter and fiscal 2010 results before the market opens on Wednesday, January 26. The Minnesota-based company, on January 12, reported healthy preliminary sales for the fourth quarter. St.
In a bid to boost its cardiovascular business, medical devices major St. Jude Medical (STJ) has struck a definitive agreement to acquire Plymouth, Minnesota-based heart devices maker AGA Medical Holdings (AGAM) for $1.3 billion.